Integrative Bioinformatics Analysis Reveals N...

Peter A Kavsak. Point of Concern for Troponin Testing with High-Sensitivity Assays in the Near Patient Setting, Clinical Chemistry, 2026; 72(10): hvag034. https://doi.org/10.1093/clinchem/hvag034 

Renal cell carcinoma has an estimated lifetime prevalence of 2.3% for men and 1.3% for women in the US. Affected patients in early stages can have >94% cancer-specific survival. Author William Y. Kim, MD, of the University of North Carolina joins JAMA Associate Editor David L. ...

Dr. Eric Singer highlights the recent rapid recommendation update from ASCO on the management of metastatic renal cell cancer (ccRCC), based on the review of evidence from the phase III COSMIC 313 trial. Dr. Singer reviews the discussion from the Expert Panel and emphasizes clini ...  Show more

In this episode, we review the high-yield topic of Renal Cell Carcinoma from the Oncology section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets 

Numri rasteve me Limfomën e kancerit të gjakut është në rritje. Dhe për këtë arsye ka rëndësi që t’i njohim simptomat e kësaj sëmundjeje.